Comparison Between Nafamostat Mesilate and Unfractionated Heparin as Anticoagulant During Continuous Renal Replacement Therapy

Critical Care - United Kingdom
doi 10.1186/cc14384
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comparison of Ulinastatin, Gabexate Mesilate, and Nafamostat Mesilate in Preservation Solution for Islet Isolation

Cell Transplantation
TransplantationBiomedical EngineeringCell Biology
2012English

Pediatric Continuous Renal Replacement Therapy

Contributions to Nephrology
Nephrology
2016English

Heparin-Induced Thrombocytopenia During Renal Replacement Therapy in the Intensive Care Unit

Critical Care
Critical CareIntensive Care Medicine
2008English

Anticoagulation for Continuous Renal Replacement Therapy

Anales del Sistema Sanitario de Navarra
Medicine
2018English

Comparison Between K3EDTA and Lithium Heparin as Anticoagulant to Isolate Bovine Granulocytes From Blood

Frontiers in Immunology
AllergyImmunology
2018English

Applying Pharmacokinetic/Pharmacodynamic Principles for Optimizing Antimicrobial Therapy During Continuous Renal Replacement Therapy

Anaesthesiology Intensive Therapy
MedicineCritical CareAnesthesiologyPain MedicineIntensive Care Medicine
2017English

Beta-Lactam Antibiotic Dosing During Continuous Renal Replacement Therapy: How Can We Optimize Therapy?

Critical Care
Critical CareIntensive Care Medicine
2014English

Heparin-Induced Hyperkalemia in a Dog Receiving Continuous Renal Replacement Treatment

Journal of Veterinary Internal Medicine
MedicineVeterinary
2015English

Pharmacokinetics of Cefepime During Continuous Renal Replacement Therapy in Critically Ill Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy